Drugs · acquisition-cost intelligence
spironolactone and hydrochlorothiazide
· ingredient hydrochlorothiazideAldosterone antagonists· HYDROCHLOROTHIAZIDE 25 mg/1; SPIRONOLACTONE 25 mg/1
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per EA
$0.53463
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per EA — the trend nobody else shows. 6 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other hydrochlorothiazide products, cheapest acquisition cost first. Per EA — confirm strength/form equivalence before switching.
| Product | NADAC / EA | vs this |
|---|---|---|
| hydrochlorothiazide | $0.01219 | −$0.52240 |
| hydrochlorothiazide | $0.02865 | −$0.50600 |
| hydrochlorothiazide | $0.03324 | −$0.50140 |
| hydrochlorothiazide | $0.04038 | −$0.49430 |
| Diovan HCT | $0.14221 | −$0.39240 |
| Avalide | $0.17972 | −$0.35490 |
| Micardis HCT | $0.36196 | −$0.17270 |
| Amiloride Hydrochloride and Hydrochlorothiazide | $0.44788 | −$0.08680 |
Medicare Part D coverage · CY2026
On 324 plan formularies · typical tier 2
Prior auth 0% · Step therapy 0% · Quantity limit 0% of formularies
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.